About Clinbiocare Technology Llp
Data last updated: 06 March 2026
Clinbiocare Technology Llp is a limited liability partnership company based in Tirunelveli, Tamil Nadu, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 05 October 2016, the LLP has been in operation for over 10 years.
Registered with ROC Chennai under LLPIN AAH-5546.
Capital: a total obligation of contribution of ₹2 Lakh. It is led by designated partners Balasankar Thangaswamy and Sivagnanam Ananthi.
Accounts filed on 31 March 2025. Office: No. 6/355 Gandhi Anna Nagar Poolangulam Village Adaikalapattinam Po, Tirunelveli, Tamil Nadu, India – 627808.
The LLP is associated with 1 brand - Clinbiocare.
For more details, the LLP can be reached via its website clinbiocaretechnology.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressNo. 6/355 Gandhi Anna Nagar Poolangulam Village Adaikalapattinam Po, Tirunelveli, Tamil Nadu, India – 627808
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Clinbiocare Technology Llp
Clinbiocare Technology Llp operates one associated brand: Clinbiocare. These brands represent Clinbiocare Technology Llp's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| A biotech institute specializing in advanced research and medical education. | clinbiocaretechnology.com |
Competitors & Alternatives of Clinbiocare Technology Llp
Brands and companies operating in the same space as Clinbiocare Technology Llp include Weill Cornell Medicine, UMC Utrecht, College of American Pathologists and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Weill Cornell Medicine
|
Provider of medical education, research, and patient care. This organization offers MD and graduate degree programs, conducts cutting-edge biomedical research, and delivers exemplary patient care through affiliated hospitals. Faculty are engaged in clinical practice and scientific discovery, translating breakthroughs into improved treatments and prevention strategies. The institution fosters a culture of mentorship and supports global health initiatives. Educational programs are highly selective and include international partnerships. Research focuses on advancing knowledge in areas such as cancer and cardiovascular disease. | United States | 1898 |
UMC Utrecht
|
Healthcare education and training services are provided to professionals. | Utrecht, Netherlands, Netherlands | 2000 |
College of American Pathologists
|
University offering multiple courses and degrees across diversified streams | Northfield, United States, United States | 1947 |
AngelEye Health
|
Provider of NICU cameras, communication, feed management, and education services for hospitals | Nashville, United States, United States | 2013 |
Pasteur Institute
|
Provider of healthcare education services | Paris, France, France | 1888 |
Conisus
|
Medical Learning solutions for healthcare professionals | Atlanta, United States, United States | 1995 |
BEACON
|
Digital therapy solution | Toronto, Canada, Canada | 2016 |
Osara Health
|
Osara Health was founded in 2015 in New York. | New York, United States, United States | 2015 |
Simple HealthKit
|
Diagnostic, digital health, and education services are provided. | Fremont, United States, United States | 2017 |
Fakeeh Care Group
|
A leading healthcare provider in Saudi Arabia, expanding into Dubai's healthcare and medical education markets. | Jeddah, Saudi Arabia, Saudi Arabia | 1978 |
Designated Partners of Clinbiocare Technology Llp
Clinbiocare Technology Llp is currently managed by 2 designated partners, with 1 former designated partner having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Balasankar Thangaswamy
Also directs:
Nandhu Organics Llp
|
Designated Partner | 05 Oct 2016 | 9 Years 9 Months | Current |
| Sivagnanam Ananthi | Designated Partner | 26 Aug 2021 | 4 Years 10 Months | Current |
Financials of Clinbiocare Technology Llp FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Charges & Borrowings Clinbiocare Technology Llp
Clinbiocare Technology Llp does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Clinbiocare Technology Llp
View historical data on people associated with Clinbiocare Technology Llp, including employment history and EPFO contributions.
Employee Count & EPFO Data of Clinbiocare Technology Llp
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Clinbiocare Technology Llp
GSTIN & GST Filing Data of Clinbiocare Technology Llp
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Clinbiocare Technology Llp
Credit Ratings, Legal Cases & Regulatory Alerts of Clinbiocare Technology Llp
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Clinbiocare Technology Llp
MSME Payment Delays by Clinbiocare Technology Llp
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Clinbiocare Technology Llp
Subsidiaries & Group Companies of Clinbiocare Technology Llp
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Clinbiocare Technology Llp with ownership details.
MCA Filings & Documents of Clinbiocare Technology Llp
MCA Filings & Documents of Clinbiocare Technology Llp
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Clinbiocare Technology Llp
Frequently Asked Questions about Clinbiocare Technology Llp
Clinbiocare Technology Llp is an active limited liability partnership in the life sciences sector based in Tirunelveli, Tamil Nadu, India. It was incorporated on 05 October 2016 (10+ years old) and is registered under LLPIN AAH-5546.
The current designated partners of Clinbiocare Technology Llp are:
The primary industry of Clinbiocare Technology Llp is life sciences. The LLP specifically operates in biotechnology. The LLP is currently active in this sector.
Yes, Clinbiocare Technology Llp is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Clinbiocare Technology Llp can be reached at the registered office: No. 6355 Gandhi Anna Nagar Poolangulam Village Adaikalapattinam Po, Tirunelveli, Tamil Nadu, India – 627808, or through the website clinbiocaretechnology.com.
The total obligation of contribution is ₹2 Lakh.